The laboratory received € 336 million from Brussels for at least 300 million doses.
According to AstraZeneca, deliveries will slow down due to a performance problem at a production site in Belgium.
In Brussels it was pointed out that doses could very well be shipped from the UK.
The Commission therefore wants to control as soon as possible the exports outside the borders of vaccines produced in Europe ...
The summary of the week
France 24 invites you to come back to the news that marked the week
I subscribe
Take international news everywhere with you!
Download the France 24 application
google-play-badge_FR